80
We report a case in which a potential drug interaction between clobazam and etravirine may have led to increased concentrations of clobazam and its pharmacologically active metabolite, N-desmethylclobazam, causing neurotoxic symptoms.
 increased concentrations of clobazam and its pharmacologically active metabolite, N-desmethylclobazam: Effect; neurotoxic symptoms: Effect; interaction between clobazam and etravirine: Treatment; etravirine: Treatment.Drug; clobazam: Treatment.Drug; clobazam: Combination.Drug; etravirine: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 increased concentrations of clobazam and its pharmacologically active metabolite, N-desmethylclobazam: Effect; neurotoxic symptoms: Effect; interaction between clobazam and etravirine: Treatment; etravirine: Treatment.Drug; clobazam: Treatment.Drug; clobazam: Combination.Drug; etravirine: Combination.Drug